# Fujirebio Europe N.V.

- Location (FDA's records): Gent
- FDA decisions: 1 (2017–2017): 1 original PMA approval
- Product codes: OBF (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- P160016: VERSANT HCV GENOTYPE 2.0 ASSAY (LiPA) (Mar 14, 2017)

Source page: https://510kreport.com/company/fujirebio-europe